Relationship between MMR vaccine and autism

Annals of Pharmacotherapy

Volumn 38, Issue 7-8, 2004, Pages 1297-1300

  Klein, Kristin C ^a,b   Diehl, Emily B ^c,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Autism; MMR vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AUTISM; CHILD; HUMAN; IMMUNIZATION; INCIDENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES;

AUTISTIC DISORDER; CHILD; CLINICAL TRIALS; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE;

EID: 3042636774     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D293     Document Type: Review

References (17)

1. Immunization safety review: measles-mumps-rubella vaccine and autism. Washington, DC: The Institute of Medicine, 2001.
2. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and persuasive developmental disorder in children. Lancet 1998;351:637-47.
3. DeStefano F. MMR vaccine and autism: a review of evidence for a causal association. Molecular Psychiatry 2002;7:S51-2.
4. Ross E. Childhood vaccine-autism study retracted. http://apnews.myway. com/article/20040304/D1384Q81.html (accessed 2004 Mar 4).
5. Measles. In: Epidemiology and prevention of vaccine-preventable diseases. The pink book. 7th ed. Atlanta: CDC Publications. April 2002: 96-114. www.cdc.gov/nip/publications/pink (accessed 2003 Dec 14).
6. Mumps. In: Epidemiology and prevention of vaccine-preventable diseases. The pink book. 7th ed. Atlanta: CDC Publications. April 2002: 115-23. www.cdc.gov/nip/publications/pink (accessed 2003 Dec 14).
7. Rubella. In: Epidemiology and prevention of vaccine-preventable diseases. The pink book. 7th ed. Atlanta: CDC Publications. April 2002: 124-38. www.cdc.gov/nip/publications/pink (accessed 2003 Dec 14).
8. UK faces mumps outbreak as parents shun MMR vaccine. Reuters Medical News. London. 2001 Aug 6. http://id.medscape.com/reuters/prof/ 2001/08/08.07/20010806publ004.html (accessed 2001 Aug 28).
9. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
10. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998;351:1327-8.
11. Patja A, Davidkin I, Kurki T, Kallio M, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 2000;19:1127-34.
12. Makela A, Nuorti JP, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 2002;110:957-63.
13. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-82.
14. Dales L, Hammer SJ, Smith N. Time trends in autism and in MMR immunization coverage in California. JAMA 2001;285:1183-5.
15. Kaye JA, Del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001;322:460-3.
16. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002;324:393-6.
17. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001;108:e58(1-8). www.pediatrics.org/cgi/content/full/108/4/e58 (accessed 2003 Dec 14).